| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.2 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.068 | 0.2 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.063 | 0.2 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | 0.046 | 0.2 |